Attruby(Acoramidis Hcl)
Medicare prescription drug cost, prescriptions and prescribers, 2024
$870K
Medicare cost, 2024
$870K
Medicare cost, 2024
Medicare drug plans spent $870,032 on Attruby (acoramidis hcl) in 2024, for 41 prescriptions and refills filled by 41 patients. It was first approved in 2024. At about $21,220 per prescription it is a high-cost drug.
Medicare cost, 2024
$870K
Prescriptions
41
$21,220.28 per claim
Patients
41
32 prescribers
Total spending, 2024
$870K
$21,220.28 per patient
Questions and answers
How much does Medicare spend on Attruby?
Medicare prescription drug plans paid $870K for Attruby in 2024, for 41 prescriptions and refills to 41 patients. The average cost per claim was $21,220.28.
Which state spends the most on Attruby?
California had the highest Medicare cost for Attruby in 2024: $202K for 11 claims.
Spending over the years
Medicare spending by year
All plans and makers
Prescriber data: cost by year
By state
Where the prescribers practice, 2024
Medicare cost by state
States with the highest cost
Prescriber data by year
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2024 | 32 | 41 | 41 | $870K |
Makers, 2024
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims | Spending |
|---|---|---|
| Bridgebio Pharm | 41 | $870K |
Medicaid spending by quarter
Amount reimbursed by state Medicaid programs, all states
Amount reimbursed
Codes
- National drug codes (packages)
- 2
- RxNorm concept IDs
- 2698318, 2698324
- Application numbers
- NDA216540
More drugs: Medicare drug spending and the Prescriptions view.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
Through September 2026, 370 side-effect reports named acoramidis hydrochloride, the active ingredient of Attruby (reports from 2025 on). 87 of them (23.5%) were serious, 12 named a death and 49 named a hospital stay. The reactions named most often were diarrhoea, fatigue and dizziness. 370 reports came in the last 5 years (since 2022).
How to read these numbers
- A report shows that a patient, doctor or drug company suspected a link. It does not prove that the drug caused the effect.
- Counts are not risk rates. They depend on how many people use the drug, how long it has been sold, news and reporting habits, so they do not show which drug is safer.
- The newest months are partial: reports keep arriving late.
Reports, all years
370
189 in 2025
Serious
23.5%
87 reports
Deaths named
12
3.2% of reports
Hospital stays
49
13.2% of reports
Reports by year
Serious reports include those that name a death, a hospital stay, a disability or another serious outcome.
Reports received by year
2026 is the year so far.
Reports naming a death or a hospital stay
One report can name both
Reactions
Reactions named most often
All years. Share = part of all reports in that period. A report can name several reactions.
Patients
As given in the reports; many reports leave sex or age out.
Sex of the patient
All years
Age of the patient
Age when the effect started, all years
Questions and answers
How many side-effect reports name Attruby?
370 reports from 2025 through September 2026 named acoramidis hydrochloride, the active ingredient of Attruby. 87 of them (23.5%) were serious, 12 named a death and 49 named a hospital stay.
What are the most reported side effects of Attruby?
69 reports named diarrhoea, the reaction named most often, followed by fatigue (29) and dizziness (23). In the last 5 years the reaction named most often was diarrhoea (69 reports). A report can name several reactions.
How many side-effect reports named Attruby in 2025?
189 reports were received in 2025. 2026 so far: 181 reports through September 2026, and more keep arriving late.
Do side-effect reports prove that Attruby caused a problem?
No. A report shows that a patient, doctor or drug company suspected a link; it does not prove that Attruby caused the effect. Report counts depend on how widely a drug is used, how long it has been sold, news and reporting habits, so they are not risk rates and do not show which drug is safer.
Related pages
- Drug approvals (1 approval on file for acoramidis hydrochloride) · Clinical trials · Medicare drug spending
Side-effect reports from official public data, counted per active ingredient (acoramidis hydrochloride) by the year the report was received, so the brand and generic pages of one ingredient show the same reports. A report can name several drugs and several reactions and counts for each. Reaction names are the standard medical terms used in the reports. Reports whose product could not be matched to a drug are not counted. Updated November 2026.